Answers are grounded in this paper and cite their sources.
Aim and Objective: To compare and to evaluate the effectiveness of MTA, PRF, and Calcium hydroxide as pulpotomy agents based on its clinical and radiographic outcomes in mature permanent teeth with irreversible pulpitis. Methods: A systematic search was conducted across PubMed, Scopus, the Cochrane Library, ScienceDirect, Google Scholar, and DELNET, covering all eligible studies published till June 2025. Randomised controlled trials that directly compared MTA, PRF, and calcium hydroxide Ch were included. The primary results assessed included postoperative pain, clinical success, and radiographic success, as well as additional results such as pulp sensitivity, cost, and overall treatment duration. The Cochrane RoB 2.0 tool was used to check for bias, and a scoring system was used to rate the level of certainty of the evidence. Because the studies were independent of each other, a qualitative synthesis was done. long-term success, with clinical and radiographic success ranging from 82%–90% up to two years. Platelet- rich fibrin alone or combined with Mineral trioxide aggregate/Bio dentine, demonstrated comparable or improved pain relief and healing, though evidence is limited by smaller sample size and shorter follow-up. Calcium hydroxide showed reduced success over time, falling below 50% at two years in one study. Conclusion: Pulpotomy with MTA and biologically enhanced materials like PRF is a promising, minimally invasive alternative to Root canal treatments in mature teeth which are diagnosed with irreversible pulpitis. Calcium hydroxide shows inferior long-term outcomes and is not recommended as a primary agent. Further larger-scale, standardized and multicentre trials are needed.
No takes yet. Share an insight, caveat, or question.
Shukla et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: